-
Crisaborole
Aha API Ngosipụta Onye mmepụta ihe Ụbọchị Mmebi Ikikere (US) Crisaborole Atopic dermatitis na eczema Pfizer -
Etelcacetide
Aha API Ngosipụta Onye mmepụta ihe Ụbọchị Mmebi Ikikere (US) Etelcacetide Hyperparathyroidism nke abụọ (HPT) Amgen -
Abemaciclib
Aha API Ngosipụta Onye mmepụta ihe Ụbọchị Mmebi Ikikere (US) Abemaciclib Ọrịa cancer ara, ọgwụgwọ ọrịa kansa prostate Eli Lily Disemba 15,2029 -
Deucracitinib
Aha API Ngosipụta Onye mmepụta ihe Ụbọchị Mmebi Ikikere (US) Deucracitinib Anti plaque psoriasis Ụlọ ọrụ Bristol-Myers Squibb Company Nov.07,2033 -
Apremilast
Aha API Ngosipụta Onye mmepụta ihe Ụbọchị Mmebi Ikikere (US) Apremilast ọrịa ogbu na nkwonkwo psoriatic Celgene -
Remdesivir
Aha API Ngosipụta Onye mmepụta ihe Ụbọchị Mmebi Ikikere (US) Remdesivir Ọgwụ nje (ọrịa Ebola, Covid-19) Gilead -
Pomalidomide
Aha API Ngosipụta Onye mmepụta ihe Ụbọchị Mmebi Ikikere (US) Pomalidomide Ọgwụ Oncology Celgene -
Nirmatrelvir
Aha API Ngosipụta Onye mmepụta ihe Ụbọchị Mmebi Ikikere (US) Nirmatrelvir 3C-dị ka Protease (3CLPRO) Inhibitor na SARS-Cov-2 Mpro Inhibitor -
Eltrombopag
Aha API Ngosipụta Onye mmepụta ihe Ụbọchị Mmebi Ikikere (US) Eltrombopag ITP & Aplastic anaemia Novartis & GSK Mee. Ọktoba 20,2023 -
Ruxolitinib
Aha API Ngosipụta Onye mmepụta ihe Ụbọchị Mmebi Ikikere (US) Ruxolitinib Myelofibrosis Novartis Julaị 6, 2024 -
Crisaborole
Aha API Ngosipụta Onye mmepụta ihe Ụbọchị Mmebi Ikikere (US) Crisaborole Atopic dermatitis na eczema Pfizer Ọnwa Isii 11, 2026